NO179867C - Sulfonamido- og sulfonamidokarbonyl-pyridin-2-karboksylsyreamider og anvendelse av forbindelsene som legemidler - Google Patents
Sulfonamido- og sulfonamidokarbonyl-pyridin-2-karboksylsyreamider og anvendelse av forbindelsene som legemidlerInfo
- Publication number
- NO179867C NO179867C NO931056A NO931056A NO179867C NO 179867 C NO179867 C NO 179867C NO 931056 A NO931056 A NO 931056A NO 931056 A NO931056 A NO 931056A NO 179867 C NO179867 C NO 179867C
- Authority
- NO
- Norway
- Prior art keywords
- pyridine
- sulfonamidocarbonyl
- sulfonamido
- drugs
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Detergent Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4209424 | 1992-03-24 | ||
| DE4238506 | 1992-11-14 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO931056D0 NO931056D0 (no) | 1993-03-23 |
| NO931056L NO931056L (no) | 1993-09-27 |
| NO179867B NO179867B (no) | 1996-09-23 |
| NO179867C true NO179867C (no) | 1997-01-02 |
Family
ID=25913130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO931056A NO179867C (no) | 1992-03-24 | 1993-03-23 | Sulfonamido- og sulfonamidokarbonyl-pyridin-2-karboksylsyreamider og anvendelse av forbindelsene som legemidler |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US5607954A (no) |
| EP (1) | EP0562512B1 (no) |
| JP (1) | JPH0649030A (no) |
| KR (1) | KR930019630A (no) |
| CN (1) | CN1076691A (no) |
| AT (1) | ATE199250T1 (no) |
| AU (1) | AU657608B2 (no) |
| CA (1) | CA2092276A1 (no) |
| CZ (1) | CZ46393A3 (no) |
| DE (1) | DE59310146D1 (no) |
| DK (1) | DK0562512T3 (no) |
| ES (1) | ES2154266T3 (no) |
| FI (1) | FI102895B1 (no) |
| GR (1) | GR3035479T3 (no) |
| HK (1) | HK1011987A1 (no) |
| HU (2) | HU219224B (no) |
| MY (1) | MY109143A (no) |
| NO (1) | NO179867C (no) |
| NZ (1) | NZ247201A (no) |
| PL (1) | PL173677B1 (no) |
| PT (1) | PT562512E (no) |
| RU (1) | RU2129545C1 (no) |
| SK (1) | SK280884B6 (no) |
| TW (1) | TW352384B (no) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0650960T3 (da) * | 1993-11-02 | 1997-09-01 | Hoechst Ag | Substituerede heterocykliske carboxylsyreamid-estere, deres fremstilling og deres anvendelse som lægemidler. |
| ATE149486T1 (de) * | 1993-11-02 | 1997-03-15 | Hoechst Ag | Substituierte heterocyclische carbonsäureamide, ihre herstellung und ihre verwendung als arzneimittel |
| NZ270267A (en) * | 1993-12-30 | 1997-03-24 | Hoechst Ag | 3-hydroxypyridin-2yl (and -quinolin-2-yl) carboxamide derivatives and pharmaceutical compositions |
| DE4410453A1 (de) * | 1994-03-25 | 1995-09-28 | Hoechst Ag | Substituierte heterocyclische Carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel |
| DE4410454A1 (de) * | 1994-03-25 | 1995-09-28 | Hoechst Ag | Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel |
| DE4410480A1 (de) * | 1994-03-25 | 1995-09-28 | Hoechst Ag | Sulfonamidocarbonylpyridin-2-carbonsäureesteramide sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE4410423A1 (de) * | 1994-03-25 | 1995-09-28 | Hoechst Ag | Sulfonamidocarbonylpyridin-2-carbonsäureamide sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| IL135495A (en) * | 1995-09-28 | 2002-12-01 | Hoechst Ag | Intermediate compounds for the preparation of quinoline-converted amines - 2 - carboxylic acid |
| DE19742951A1 (de) | 1997-09-29 | 1999-04-15 | Hoechst Schering Agrevo Gmbh | Acylsulfamoylbenzoesäureamide, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung |
| DE19746287A1 (de) * | 1997-10-20 | 1999-04-22 | Hoechst Marion Roussel De Gmbh | Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel |
| AR015733A1 (es) * | 1998-03-25 | 2001-05-16 | Otsuka Pharma Co Ltd | DERIVADO DE PIRIDINA, EL PRODUCTO Y LA COMPOSICIoN FARMACEUTICA QUE CONTIENE DICHO DERIVADO. |
| US6583318B2 (en) | 2001-05-17 | 2003-06-24 | Advanced Syntech, Llc | Method for synthesis of α-sulfonamido amide, carboxylic acid and hydroxamic acid derivatives |
| ES2686625T3 (es) | 2001-12-06 | 2018-10-18 | Fibrogen, Inc. | Métodos para el tratamiento o prevención de la anemia |
| EP2295060B1 (en) | 2001-12-06 | 2018-10-31 | Fibrogen, Inc. | Treatment or prevention of ischemic or hypoxic conditions |
| US7618940B2 (en) * | 2002-12-06 | 2009-11-17 | Fibrogen, Inc. | Fat regulation |
| US8124582B2 (en) | 2002-12-06 | 2012-02-28 | Fibrogen, Inc. | Treatment of diabetes |
| US8614204B2 (en) | 2003-06-06 | 2013-12-24 | Fibrogen, Inc. | Enhanced erythropoiesis and iron metabolism |
| EP1919463B9 (en) | 2005-06-15 | 2011-02-02 | Fibrogen, Inc. | Use of hif 1alfa modulators for treatment of cancer |
| BRPI0710048A2 (pt) * | 2006-03-30 | 2011-08-02 | Lg Electronics Inc | método e aparelho para decodificar / codificar um sinal de vìdeo |
| EP2327696A1 (en) | 2006-06-26 | 2011-06-01 | Warner Chilcott Company, LLC | Prolyl hydroxylase inhibitors and methods of use |
| NZ581309A (en) * | 2007-05-25 | 2012-02-24 | Vertex Pharma | Ion channel modulators and methods of use |
| US8962530B2 (en) * | 2007-06-27 | 2015-02-24 | Regents Of The University Of Colorado | Inflammatory bowel disease therapies |
| NO2686520T3 (no) | 2011-06-06 | 2018-03-17 | ||
| US9458147B2 (en) | 2012-02-22 | 2016-10-04 | Sanford-Burnham Medical Research Institute | Sulfonamide compounds and uses as TNAP inhibitors |
| TW201512171A (zh) | 2013-04-19 | 2015-04-01 | Pfizer Ltd | 化學化合物 |
| RU2019134558A (ru) | 2013-06-13 | 2020-02-20 | Экебиа Терапьютикс, Инк. | Композиции и способы лечения анемии |
| AU2014348523B2 (en) | 2013-11-15 | 2019-01-03 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof |
| EP3247355A4 (en) | 2015-01-23 | 2018-06-13 | Akebia Therapeutics, Inc. | Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof |
| CN106146395B (zh) * | 2015-03-27 | 2019-01-01 | 沈阳三生制药有限责任公司 | 3-羟基吡啶化合物、其制备方法及其制药用途 |
| SG11201707994UA (en) | 2015-04-01 | 2017-10-30 | Akebia Therapeutics Inc | Compositions and methods for treating anemia |
| CN112088155A (zh) | 2018-05-09 | 2020-12-15 | 阿克比治疗有限公司 | 用于制备2-[[5-(3-氯苯基)-3-羟基吡啶-2-羰基]氨基]乙酸的方法 |
| US11524939B2 (en) | 2019-11-13 | 2022-12-13 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid |
| CN111972405A (zh) * | 2020-07-27 | 2020-11-24 | 南京太化化工有限公司 | 一种悬浮剂用助剂及异恶唑草酮悬浮剂 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3432094A1 (de) * | 1984-08-31 | 1986-03-06 | Hoechst Ag, 6230 Frankfurt | Ester der pyridin-2,4- und -2,5- dicarbonsaeure als arzneimittel zur inhibierung der prolin- und lysinhydroxylase |
| US5153208A (en) * | 1987-02-10 | 1992-10-06 | Hoechst Aktiengesellschaft | Pyridine-2,4- and -2,5-dicarboxylic acid amides and their medicinal compositions and methods of use |
| DE3703962A1 (de) * | 1987-02-10 | 1988-08-18 | Hoechst Ag | Pyridin-2,4- und 2,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen |
| DE3703959A1 (de) * | 1987-02-10 | 1988-08-18 | Hoechst Ag | Pyridin-2,4- und 2,5-dicarbonsaeureamide, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen |
| DE3928144A1 (de) * | 1989-08-25 | 1991-02-28 | Hoechst Ag | Zyklische pyridin-2,4- und -2,5-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung |
| DE4020570A1 (de) * | 1990-06-28 | 1992-01-02 | Hoechst Ag | 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung |
-
1993
- 1993-03-09 TW TW082101698A patent/TW352384B/zh active
- 1993-03-19 NZ NZ247201A patent/NZ247201A/xx unknown
- 1993-03-22 DE DE59310146T patent/DE59310146D1/de not_active Expired - Fee Related
- 1993-03-22 CZ CZ93463A patent/CZ46393A3/cs unknown
- 1993-03-22 SK SK223-93A patent/SK280884B6/sk unknown
- 1993-03-22 ES ES93104658T patent/ES2154266T3/es not_active Expired - Lifetime
- 1993-03-22 DK DK93104658T patent/DK0562512T3/da active
- 1993-03-22 MY MYPI93000506A patent/MY109143A/en unknown
- 1993-03-22 PT PT93104658T patent/PT562512E/pt unknown
- 1993-03-22 AT AT93104658T patent/ATE199250T1/de not_active IP Right Cessation
- 1993-03-22 FI FI931250A patent/FI102895B1/fi active
- 1993-03-22 EP EP93104658A patent/EP0562512B1/de not_active Expired - Lifetime
- 1993-03-23 NO NO931056A patent/NO179867C/no not_active IP Right Cessation
- 1993-03-23 JP JP5063723A patent/JPH0649030A/ja active Pending
- 1993-03-23 PL PL93298195A patent/PL173677B1/pl unknown
- 1993-03-23 RU RU93004764A patent/RU2129545C1/ru active
- 1993-03-23 CN CN93103349A patent/CN1076691A/zh active Pending
- 1993-03-23 CA CA002092276A patent/CA2092276A1/en not_active Abandoned
- 1993-03-23 AU AU35369/93A patent/AU657608B2/en not_active Ceased
- 1993-03-24 KR KR1019930004589A patent/KR930019630A/ko not_active Application Discontinuation
- 1993-03-24 HU HU9300850A patent/HU219224B/hu not_active IP Right Cessation
-
1994
- 1994-12-13 US US08/355,419 patent/US5607954A/en not_active Expired - Fee Related
-
1995
- 1995-01-17 HU HU95P/P00068P patent/HU210714A9/hu unknown
-
1998
- 1998-12-11 HK HK98113239A patent/HK1011987A1/xx not_active IP Right Cessation
-
2001
- 2001-02-28 GR GR20010400321T patent/GR3035479T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO179867C (no) | Sulfonamido- og sulfonamidokarbonyl-pyridin-2-karboksylsyreamider og anvendelse av forbindelsene som legemidler | |
| MY110110A (en) | Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders | |
| FI940072A (fi) | Pyrrolidiinijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet | |
| MX9201760A (es) | Quinoxalinas, procedimiento para su preparacion y su empleo. | |
| NO953367D0 (no) | Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler | |
| ATE157088T1 (de) | Neue chinolon- und naphthyridoncarbonsäurederivate | |
| ES2126684T3 (es) | Utilizacion de derivados de acidos carboxilicos aromaticos para la preparacion de medicamentos. | |
| ES2039267T3 (es) | Dihidropiridinamidas, procedimiento para su preparacion y su empleo en medicamentos. | |
| ATE172721T1 (de) | Aminosäurederivate und ihre verwendung als enkephalinase-inhibitoren | |
| TR27833A (tr) | Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu. | |
| DK284588A (da) | Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler. | |
| DE3872425D1 (de) | Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel. | |
| NO180085C (no) | Acylsulfonamido- og sulfonamidopyridin-2-karboksylsyreestere og deres anvendelse som legemidler | |
| DE59307401D1 (de) | Alpha-Aryl-alpha-hydroxy-beta-imidazolinylpropionsäureamide | |
| NO933465D0 (no) | Legemidler inneholdende 1,5,6,7-tetrahydro -4- indazol -4- on-derivater, nye 1,5,6,7 - tetrahydro -4- indazol -4- on-derivater, og fremgangsmaate for deres fremstilling | |
| SU1783774A1 (ru) | Натриевая соль n-(3-хлорбутен-2-ил)антраниловой кислоты, проявляющая противовоспалительную и анальгетическую активность |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN SEPTEMBER 2002 |